1 antenatal updates Michelle Onslow

1. Public Health England is responsible for the NHS Screening Programmes
Quality Assurance (London)
Antenatal Updates
Michelle Onslow, Senior QA Advisor

2. Sickle Cell and Thalassaemia
• Review of failsafe processes the Map of Medicine
pathways – mapping incidents against the pathway
• Reviewing of UK NSC publications, educational resources
and NHS Choices
• Looking at the main reasons why women present late for
booking – aiming to focus resources in key areas
• IVF/Fertility – screening often undertaken if donor eggs
used but not if using their own, National programme doing
communication on this in conjunction with voluntary
agencies
• 2016/17 service specification to be released soon
2 Presentation title - edit in Header and Footer

3. Sickle Cell and Thalassaemia
• Courses at KCL – funded places
being offered:
Short counselling course – for non
specialists, 19th November and 21st
April 2016 both in London.
Genetic risk assessment and
counselling module, four day course for
staff delivering counselling 12th/13th
May 2016 and 16th/17th June 2016
Email sent out yesterday with
instructions
http://cpd.screening.nhs.uk/sct-
externaltraining
3 Presentation title - edit in Header and Footer

4. Sickle Cell and Thalassaemia
• SC&T e-learning resource:
Target audience, midwives, health visitors, GP’s and
counsellors
Nine modules that follow the screening pathway
Films on completing the FOQ, partner testing and
giving positive results
Information on sickle cell complications, thalassaemia
complications and a world map of prevalence
Tips on talking to parents, links to key resources and
quiz/test and certificate
Coming soon: http://cpd.screening.nhs.uk/
4 Presentation title - edit in Header and Footer

5. Sickle Cell and Thalassaemia
• PND Outcome forms:
 Short term: Decision following PND
 Long term: Pregnancy outcome, delivery etc.
 Completion and return of the forms is low
 Lack of evidence at National level to inform
standards, KPI’s etc.
 We will now look for evidence that these are
completed and returned as part of a QA visit
 Included as part of policy, evidence of a process in
place for completion and return of the forms
5 Presentation title - edit in Header and Footer

6. FASP
• New Standards:
 Nine new standards
 Some data required from local providers, some
collected nationally, most already collected via KPI’s
annual reports etc.
 National submission template with instructions
coming soon
6 Presentation title - edit in Header and Footer

7. FASP
• T13/18:
 Written consent not required but there must be clear
documentation of the offer + acceptance/decline of
T21 and T13/18
 Request form needs to have an option to accept or
decline T21 and T13/18 separately
 Report must have two risks one for T21 and one for
T13/18
 Parents must be aware that PND would identify a
result for all three conditions regardless of risk results
 Most Trusts directly contract the lab – you can
influence change
7 Presentation title - edit in Header and Footer

8. FASP
• KPI FA2 Pilot:
 Overall positive feedback from the units that took part
– many continuing to submit
 Some challenges identified – IT, correct identification
of the cohort
 A number of women were identified as missed
 Failsafe’s not in place
 Recommending that it is introduced as a KPI
 Awaiting a National decision – will provide more detail
as soon as we know
8 Presentation title - edit in Header and Footer

9. Infectious Diseases
• New standards, 2016/17 service specification, laboratory
and operational handbooks
• Regional roll out workshops Jan-March 2016
• Cessation of Rubella: No decision made yet, awaiting
ministerial sign off, we will update you as soon as we
know
• New e-learning resource coming next year
• New Hep B and HIV leaflets, leaflets translated into 20
different languages, available to download
9 Presentation title - edit in Header and Footer

10. Infectious Diseases
• Professional forum, midwives, nurse specialists, self
nominated members, helping to produce educational
resources
• Women who decline:
 Evidence to show they have a higher prevalence of
HIV
 Need a robust pathway for re-offer
 Should see screening team or specialist
• ‘Late Booking’ will become 20 weeks gestation – due to
commencement of antiretroviral therapy
• Request form needs to include acceptance and decline
for each condition
10 Presentation title - edit in Header and Footer

11. Infectious Diseases
• Results should be given by an appropriately trained
clinician (including Hep B)
• New KPI’s for coverage for Hep B & Syphilis
• ID2: being reviewed based on findings from national
audit
• Looking at all data collected:
 streamlining to reduce duplication of requests
 ensure consistency
 simplify the process
 Online data reporting system
11 Presentation title - edit in Header and Footer

12. General
• Screening Blog: https://phescreening.blog.gov.uk
 All up to date information re: screening
 Sign up to receive updates
 Email cascades will stop so if you are not signed up
you won’t know!
 If you would like to do a blog contact us
• London QA Service have a new email address:
 PHE.LondonQA@nhs.net
 The old address (PHE.screeningqalondon@nhs.net)
will be deactivated on 01.11.15
12 Presentation title - edit in Header and Footer

13. General
• Annual reports 2014/15:
 QA Team will not be doing individual feedback reports
 General London wide presentation at the next forum
 Local feedback at your TSSG
 Template will be reviewed nationally once new
standards are published to reduce duplication etc.
• NMC Revalidation:
 Remind staff looking for CPD evidence of the free
NSC e-learning resources
13 Presentation title - edit in Header and Footer